IP Library Granted Patent US 11,191,931
Granted Patent B2
US 11,191,931 · App. 12/681,125 · Granted Dec 7, 2021

Methods for manually injecting/aspirating fluids through small diameter catheters and needles and manual injection/aspiration systems including small diameter catheters and needles

Inventor: Shawn P. Fojtik (Park City, UT)
Assignee: PMT PARTNERS, LLC
A61M25/10182A61B5/1405A61B5/153A61B5/15003A61B5/150236A61B5/150244A61M5/1452A61M5/315A61M25/104A61B5/4514A61B17/00491A61F2/958A61M5/007A61M5/31581A61M2005/3125A61M2205/3331
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,191,931
App. No.
12/681,125
Granted
Dec 7, 2021
Kind
B2
Abstract

A system for increasing rates at which fluids may be manually forced through injection/aspiration elements, such as catheters and needles, includes the injection/aspiration elements, as well as a syringe including a pair of crossed handles, one associated with the barrel of the syringe, the other associated with the plunger of the syringe, to provide a mechanical advantage. The system may include and injection/aspiration element of small (e.g., 0.052 inch or smaller) inner diameter and small outer diameter (e.g., 5 French or less). Such systems enable the use of a single hand to hold and operate a syringe in a variety or procedures, including angiography, angioplasty, discography, glue/cement injection, and a variety of aspiration procedures (e.g., biopsy, sampling, media removal, etc.).

Claims (39)

1. A hand-held angiography system comprising:

a catheter including a proximal end, a distal end, and an outer diameter of less than 6 French;

contrast media; and

a hand-held, hand-operated syringe, including:

a syringe barrel that couples to the proximal end of the catheter;

a plunger within the syringe barrel and movable along a length of the syringe barrel; and

a handle including:

a first member including a gripping end, an intermediate portion, and a plunger attachment end pivotally coupled to the plunger;

a second member including a gripping end, an intermediate portion, and a barrel attachment end pivotally coupled to the syringe barrel; and

a hinge pivotally coupling the intermediate portion of the first member and the intermediate portion of the second member,

the first member, the second member, and the hinge having a crossing pivotal arrangement that provides a mechanical advantage that enables the hand-held, hand-operated syringe to force the contrast media into and through the catheter at a substantially constant rate of at least 0.5 mL/s that optimizes a density of contrast-enhanced images while an individual operates the handle with one hand without further assistance.

2. The hand-held angiography system of claim 1 , wherein the syringe barrel comprises a cylindrically shaped recess defined therein and sized to couple to the proximal end of the catheter.

3. The hand-held angiography system of claim 1 , wherein the hand-held, hand-operated syringe is capable of forcing the contrast media through the catheter at a rate equal to or greater than about 0.5 mL/second.

4. The hand-held angiography system of claim 1 , wherein the hand-held, hand-operated syringe is capable of forcing the contrast media through the catheter at a rate equal to or greater than about 1.0 mL/second.

5. The hand-held angiography system of claim 1 , wherein the hand-held, hand-operated syringe is capable of forcing the contrast media through the catheter at a rate equal to or greater than about 2.0 mL/second.

6. The hand-held angiography system of claim 1 , wherein the hand-held, hand-operated syringe is capable of forcing the contrast media through the catheter at a rate equal to or greater than about 3.0 mL/second.

7. The hand-held angiography system of claim 1 , wherein the hand-held, hand-operated syringe is capable of forcing the contrast media through the catheter at a rate equal to or greater than about 5.0 mL/second.

8. The hand-held angiography system of claim 1 , wherein the outer diameter of the catheter is no more than 5 French.

9. The hand-held angiography system of claim 1 , wherein the outer diameter of the catheter is no more than 4 French.

10. The hand-held angiography system of claim 1 , wherein the catheter is of a length of at least about 65 cm.

11. The hand-held angiography system of claim 1 , wherein the hand-held, hand-operated syringe comprises an injection syringe, with the gripping end of the first member capable of being manipulated by at least one finger of an individual's hand and the gripping end of the second member capable of being held in place by a thumb or a palm of the user's hand.

12. The hand-held angiography system of claim 1 , wherein the hand-held, hand-operated syringe comprises an aspiration syringe, with the gripping end of the first handle member capable of being held in place by a thumb or a palm of a user's hand and the gripping end of the second handle member capable of being manipulated by at least one finger of the individual's hand.

13. The hand-held angiography system of claim 1 , wherein a length of the first member of the handle of the hand-held, hand-operated syringe is greater than a length of the second member of the handle of the hand-held, hand-operated syringe.

14. A hand-held catheter system comprising:

a balloon catheter including a distal end for insertion into a body of a subject, a balloon adjacent to the distal end, and a proximal end, the balloon catheter having an outer diameter of less than 6 French;

a hand-held, hand-operated syringe, including:

a syringe barrel that couples to the proximal end of the balloon catheter;

a plunger within the syringe barrel and movable along a length of the syringe barrel; and

a handle including:

a first member including a gripping end, an intermediate portion, and a plunger attachment end pivotally coupled to the plunger;

a second member including a gripping end, an intermediate portion, and a barrel attachment end pivotally coupled to the syringe barrel; and

a hinge pivotally coupling the intermediate portion of the first member and the intermediate portion of the second member,

the first member, the second member, and the hinge having a crossing pivotal arrangement that provides a mechanical advantage sufficient to inflate the balloon of the balloon catheter at a substantially constant rate while an individual operates the handle with one hand without further assistance.

15. The hand-held catheter system of claim 14 , wherein the balloon catheter comprises an angioplasty balloon catheter.

16. The hand-held catheter system of claim 14 , further comprising:

a stent carried by the balloon of the balloon catheter.

17. The hand-held catheter system of claim 14 , wherein the balloon catheter has an outer diameter of 5 French or less.

18. The hand-held catheter system of claim 17 , wherein the balloon catheter is a 4 French balloon catheter.

19. The hand-held catheter system of claim 14 , wherein a length of the first member of the handle of the hand-held, hand-operated syringe is greater than a length of the second member of the handle of the hand-held, hand-operated syringe.

Assignments (11)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF THE ASSIGNEE TO PMT PARTNERS, LLC PREVIOUSLY RECORDED AT REEL: 034133 FRAME: 0071. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 24, 2014
From: MALLINCKRODT LLC
To: PMT PARTNERS, LLC
Reel/Frame 034443/0334 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2014
From: MALLINCKRODT LLC
To: PMT, LLC
Reel/Frame 034133/0071 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2013
From: COVIDIEN AG
To: MALLINCKRODT LLC
Reel/Frame 030793/0139 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE COUNTRY SHOULD BE SWITZERLAND NOT NETHERLANDS IN CHANGE OF ADDRESS PREVIOUSLY RECORDED ON REEL 024875 FRAME 0331. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNEE COUNTRY SHOULD BE SWITZERLAND NOT NETHERLANDS IN CHANGE OF ADDRESS. Recorded Aug 25, 2010
From: COVIDIEN AG
To: COVIDIEN AG
Reel/Frame 024885/0935 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 24, 2010
From: PINYONS MEDICAL TECHNOLOGY, INC.
To: COVIDIEN AG
Reel/Frame 024875/0169 →
CHANGE OF ADDRESS Recorded Aug 24, 2010
From: COVIDIEN AG
To: COVIDIEN AG
Reel/Frame 024875/0331 →
MERGER Recorded Aug 24, 2010
From: COVIDIEN AG
To: TYCO HEALTHCARE GROUP AG
Reel/Frame 024875/0525 →
CHANGE OF NAME Recorded Aug 24, 2010
From: TYCO HEALTHCARE GROUP AG
To: COVIDIEN AG
Reel/Frame 024876/0112 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 24, 2010
From: FOJTIK, SHAWN P.
To: PINYONS MEDICAL TECHNOLOGY, INC.
Reel/Frame 024875/0083 →
Continuity (2)
Continuation In Part 11865626 · Oct 1, 2007
Related Publication 20100249719A1 · Sep 30, 2010
Cited By (2)
US 12,588,926 US 12,708,400